These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11364243)

  • 1. ABT-378: Abbott "second generation" protease inhibitor.
    James JS
    AIDS Treat News; 1997 Feb; (No 265):6. PubMed ID: 11364243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors: resistance, resistance, resistance.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More clinical data on protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Oct; 9(10):4-7. PubMed ID: 11362917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease inhibitor new math.
    Gilden D
    GMHC Treat Issues; 1996 May; 10(5):3-6. PubMed ID: 11363583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delavirdine/protease inhibitor interactions.
    Gilden D
    GMHC Treat Issues; 1996 Sep; 10(9):11-2. PubMed ID: 11363839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease uninhibited.
    Notes Undergr; 1996 Apr; (no 32):suppl 1-2. PubMed ID: 11363451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral resistance to protease inhibitors.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):1, 4-5. PubMed ID: 11362685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance to protease inhibitors].
    Clotet B; Martínez-Picado J; Arrizabalaga J; Ruiz L
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):34-41. PubMed ID: 11428058
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug works in treatment-naive, experienced patients.
    AIDS Alert; 1999 Dec; 14(12):136. PubMed ID: 11366988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [No resistance even after 1 year. New drug combination against HIV].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():108. PubMed ID: 11373766
    [No Abstract]   [Full Text] [Related]  

  • 12. Protease inhibitor studies enrolling.
    Treat Rev; 1995; (no 17):3. PubMed ID: 11362296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded access program for ABT-378 under way.
    Slovick J
    Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ICAAC: new drugs in late breaker session.
    James JS
    AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior virological efficacy of ritonavir-boosted protease inhibitor regimens compared to single protease inhibitor therapy.
    Lichterfeld M; Wöhrmann A; Schmeisser N; Fätkenheuer G; Salzberger B; Wyen C; Schmitz K; Sauerbruch T; Rockstroh JK
    Eur J Med Res; 2003 Feb; 8(2):56-60. PubMed ID: 12626282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of virologic response to ritonavir-boosted protease inhibitors.
    Marcelin AG; Flandre P; Peytavin G; Calvez V
    AIDS Rev; 2005; 7(4):225-32. PubMed ID: 16425962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease inhibitor update.
    Colvin R; Haas G
    Common Factor; 1995 Apr; (no 10):15. PubMed ID: 11362340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABT-378 early access program begins.
    AIDS Treat News; 1999 Oct; (No 328):1-2. PubMed ID: 11366816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy.
    Kempf DJ; Isaacson JD; King MS; Brun SC; Sylte J; Richards B; Bernstein B; Rode R; Sun E
    Antivir Ther; 2002 Sep; 7(3):165-74. PubMed ID: 12487383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.
    Sahali S; Chaix ML; Delfraissy JF; Ghosn J
    AIDS Rev; 2008; 10(1):4-14. PubMed ID: 18385776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.